Comparing Stellate Ganglion Block and Oral Medications for Sweaty Palms
The Efficacy of Stellate Ganglion Block Versus Combined Oral Anticholinergic and Antidepressant Drugs on Treatment of Palmar Hyperhidrosis; A Randomized Comparative Study
This study is trying to see if a nerve block or a mix of oral medications works better for people aged 20 to 45 with sweaty palms.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 20 Years to 45 Years |
| Sex | All |
| Sponsor | Fayoum University Academic / other |
| Locations | 1 site (Fayoum) |
| Trial ID | NCT06731101 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effectiveness of a stellate ganglion block against a combination of oral anticholinergic and antidepressant medications in treating palmar hyperhidrosis, a condition characterized by excessive sweating of the palms. Participants aged 20 to 45 with primary palmar hyperhidrosis will be enrolled, and their responses to the two treatment approaches will be evaluated. The study seeks to determine which method provides better relief from symptoms and improves quality of life for affected individuals.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 20 to 45 who experience primary palmar hyperhidrosis.
Not a fit: Patients who are unable to cooperate or have known allergies to anticholinergic or antidepressant drugs may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a more effective treatment option for patients suffering from palmar hyperhidrosis.
How similar studies have performed: While there have been studies on treatments for hyperhidrosis, the specific comparison of stellate ganglion block versus oral medications in this context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: - 1. Age from 20 to 45 years. 2. Both genders. 3. Exhibiting primary palmar hyperhidrosis. Exclusion criteria: - 1. An inability of patient to cooperate. 2. Known allergies to anticholinergic or antidepressant drugs.
Where this trial is running
Fayoum
- Taha mohamed agmy — Fayoum, Egypt (Recruiting)
Study contacts
- Principal investigator: Atef M Khalil, professor — Fayoum University
- Study coordinator: Taha M Agmy, Master
- Email: tma11@fayoum.edu.eg
- Phone: 01015909635
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.